Susanna A. McColley

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

Philip M. Farrell, Terry B. White, Clement L. Ren et al. · The Journal of Pediatrics · 2017 · 929 citations · Full text

Medicine, Genetics, Pediatrics +16

Inability of Clinical History to Distinguish Primary Snoring From Obstructive Sleep Apnea Syndrome in Children

John L. Carroll, Susanna A. McColley, Carole L. Marcus et al. · CHEST Journal · 1995 · 649 citations · Full text

Medicine, Child Health, Pediatrics +17

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

Michael Boyle, Scott C. Bell, Michael W. Konstan et al. · The Lancet Respiratory Medicine · 2014 · 442 citations

Pharmacy, Molecular Genetics, Pharmacotherapy +11

Respiratory Compromise After Adenotonsillectomy in Children With Obstructive Sleep Apnea

Susanna A. McColley, Max M. April, John L. Carroll et al. · Archives of Otolaryngology - Head and Neck Surgery · 1992 · 360 citations

Medicine, Otolaryngology, Pediatrics +13